$13.78
0.12[0.88%]
At close: Apr 23
$13.78
0[0.00%]
After Hours: 4:20PM EDT
Sabra Health Care REIT
(NASDAQ:SBRA)Sabra Health Care REIT Stock (NASDAQ:SBRA), Analyst Ratings, Price Targets, Predictions
Sabra Health Care REIT Inc has a consensus price target of $12.69, established from looking at the 33 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Mizuho, and Stifel on January 30, 2024, January 3, 2024, and November 7, 2023. With an average price target of $18 between Deutsche Bank, Mizuho, and Stifel, there's an implied 30.62% upside for Sabra Health Care REIT Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
Mizuho
Stifel
Wells Fargo
BMO Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sabra Health Care REIT
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/30/2024 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 52.39% | Deutsche Bank | Omotayo Okusanya | → $21 | Initiates | → Buy | Get Alert |
| 01/03/2024 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 23.37% | Mizuho | Vikram Malhotra | $15 → $17 | Maintains | Buy | Get Alert |
| 11/07/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 16.11% | Stifel | Stephen Manaker | $14 → $16 | Maintains | Buy | Get Alert |
| 10/17/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 8.85% | Wells Fargo | Connor Siversky | $13 → $15 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 16.11% | BMO Capital | John Kim | → $16 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/16/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 8.85% | Wells Fargo | Connor Siversky | → $15 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/10/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | — | B of A Securities | Joshua Dennerlein | — | Upgrade | Neutral → Buy | Get Alert |
| 10/03/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 16.11% | Wedbush | Richard Anderson | → $16 | Initiates | → Outperform | Get Alert |
| 09/20/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 8.85% | Jefferies | Jonathan Petersen | $11 → $15 | Upgrade | Hold → Buy | Get Alert |
| 08/11/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | 1.6% | B of A Securities | Joshua Dennerlein | $11 → $14 | Upgrade | Underperform → Neutral | Get Alert |
| 07/27/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -5.66% | Berenberg | Tao Qiu | → $13 | Initiates | → Hold | Get Alert |
| 07/14/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -9.29% | Citigroup | Nicholas Joseph | $11 → $12.5 | Maintains | Neutral | Get Alert |
| 04/25/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -5.66% | Barclays | Steve Valiquette | $15 → $13 | Maintains | Equal-Weight | Get Alert |
| 04/20/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -20.17% | Wells Fargo | Connor Siversky | → $11 | Initiates | → Underweight | Get Alert |
| 04/19/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -20.17% | Wells Fargo | Connor Siversky | → $11 | Initiates | → Underweight | Get Alert |
| 04/12/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -5.66% | Credit Suisse | Omotayo Okusanya | → $13 | Reiterates | → Neutral | Get Alert |
| 03/29/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -5.66% | Truist Securities | Michael Lewis | $14 → $13 | Maintains | Buy | Get Alert |
| 03/28/2023 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | -23.8% | Citigroup | Nicholas Joseph | $13 → $10.5 | Maintains | Neutral | Get Alert |
| 12/13/2022 | SBRA | Buy Now | Sabra Health Care REIT | $13.78 | — | JMP Securities | Aaron Hecht | — | Downgrade | Market Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Sabra Health Care REIT (SBRA)?
The latest price target for Sabra Health Care REIT (NASDAQ: SBRA) was reported by Deutsche Bank on January 30, 2024. The analyst firm set a price target for $21.00 expecting SBRA to rise to within 12 months (a possible 52.39% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sabra Health Care REIT (SBRA)?
The latest analyst rating for Sabra Health Care REIT (NASDAQ: SBRA) was provided by Deutsche Bank, and Sabra Health Care REIT initiated their buy rating.
When was the last upgrade for Sabra Health Care REIT (SBRA)?
The last upgrade for Sabra Health Care REIT Inc happened on October 16, 2023 when Wells Fargo raised their price target to $15. Wells Fargo previously had an underweight for Sabra Health Care REIT Inc.
When was the last downgrade for Sabra Health Care REIT (SBRA)?
The last downgrade for Sabra Health Care REIT Inc happened on October 17, 2023 when BMO Capital changed their price target from N/A to $16 for Sabra Health Care REIT Inc.
When is the next analyst rating going to be posted or updated for Sabra Health Care REIT (SBRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sabra Health Care REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sabra Health Care REIT was filed on January 30, 2024 so you should expect the next rating to be made available sometime around January 30, 2025.
Is the Analyst Rating Sabra Health Care REIT (SBRA) correct?
While ratings are subjective and will change, the latest Sabra Health Care REIT (SBRA) rating was a initiated with a price target of $0.00 to $21.00. The current price Sabra Health Care REIT (SBRA) is trading at is $13.78, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.